Single Ascending Dose Study of AMG 570 in Healthy Subjects

Clinical trial NCT02618967 · COMPLETED

Trial details

NCT number: NCT02618967
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2016-03-28
Primary completion: 2018-09-06
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.